BioWorld MedTech

April 4, 2011

ACOs set to change device maker, customer relationship

ATLANTA – With the impending formation of Accountable Care Organizations (ACOs), med-tech companies will have to alter the way they market their products to customers – because the customers will change. (Medical Device Daily) Read More

Radioembolization, the newest liver cancer-busting treatment

Washington roundup: Matrixx decision could prompt more data dumps in SEC filings

Palomar releases Icon Laser and Optimized Light System

International report: Best Medical Belgium acquires MDS Nordion

Court Report: Medtronic wins suit over Boston Sci heart patents

MDD's Fun Facts

Deals roundup: 3M reports the acquisition of assets from Zargis Medical

HIT roundup: SXC to provide PBM services for Nevada Medicaid program

Financings roundup: Thoratec to redeem all outstanding senior notes

Agreements/contracts: AutoGenomics expands molecular testing with PGXL

Product Briefs

People in the News

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 24, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 24, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Left: Anthony Fauci. Right: Transmission electron micrograph of HIV-1 virus particles

HIV research is close to a cure but far from ending the pandemic

BioWorld

Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...

Illustration of tau accumulating in a neuron cell.

ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug

BioWorld

ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...